v3.26.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule Components of the Company's Income Tax Expense
The components of the Company’s income tax expense for the years ended December 31, 2025 and 2024, were as follows:
 
    
2025
    
2024
 
Current taxes:
     
Foreign
   $ 8,883      $ 5,252  
  
 
 
    
 
 
 
Total income tax expense/(benefit)
   $   8,883      $   5,252  
  
 
 
    
 
 
 
Schedule of a Reconciliation of the Company's Effective Tax Rate to the U.S. Federal Statutory Income Tax Rate
A reconciliation of the Company’s effective tax rate to the U.S. federal statutory income tax rate for the years ended December 31, 2025 and 2024, is as follows:
 
    
 2025 
   
 2025 
   
 2024 
   
 2024 
 
Federal statutory rate
     1,912,292       21.00     1,997,362       21.00
Foreign Tax Effect
     (2,665     0.00     (2,719     -0.03
Permanent Differences
     1,934       0.00     3,811       0.04
Valuation allowance
     (1,794,202     -19.70     (1,987,047     -20.89
Effect of cross-border tax laws
     (7,628     -0.10       (7,482     -0.08  
Nontaxable or nondeductible items
     (99,885     -1.10     (9,177     -0.10
Other
     (18,729     -0.20     -         0.00
  
 
 
   
 
 
   
 
 
   
 
 
 
Effective tax rate
     (8,883     (0.1 )%      (5,252     (0.06 )% 
  
 
 
   
 
 
   
 
 
   
 
 
 
Schedule of Deferred Tax Assets And Liabilities
Deferred tax assets and liabilities as of December 31, 2025 and 2024, consisted of the following:
 
    
2025
   
2024
 
Deferred tax assets
            
Net operating losses
   $ 2,850,031     $ 890,289  
Lease liability
     205,630       215,272  
Capitalized research and development
     2,589,415       2,420,060  
Research and develpoment credit
     348,597       157,265  
Stock-based compensation
     18,276       20,815  
Fixed Asset
     21,887       -    
  
 
 
   
 
 
 
Total deferred tax assets
       6,033,836     $   3,703,701  
  
 
 
   
 
 
 
Deferred tax liabilities
    
ROU asset
     (192,565     (207,413
Fixed Asset
     -          (246,330
  
 
 
   
 
 
 
Total deferred tax liabilities
     (192,565     (453,743
  
 
 
   
 
 
 
Less: valuation allowance
     (5,841,271     (3,249,958
  
 
 
   
 
 
 
Total
   $ -        $ -     
  
 
 
   
 
 
 
Schedule of Operating Loss Carryforwards And Tax Credit
As of December 31, 2025, the Company had the following net operating loss (“NOL”) and tax credit carryforwards:
 
    
Amount
    
Expiration
 
U.S. federal NOL
   $
7,184,853
       Indefinite  
State (California) NOL
       
19,205,159
      
  2042-2045
 
California research and development credit
    
441,261
       2026-2030  
U.S. federal research and development payroll tax credit
    
692,518
       2029-2030  
Schedule of a Reconciliation of the Beginning and Ending Amounts of Unrecognized Tax Benefits
A reconciliation of the beginning and ending amounts of unrecognized tax benefits for the years ended December 31, 2025 and 2024, is as follows:
 
    
2025
   
  
2024
 
Balance at beginning of year
     (35,130        -  
Increase/(Decrease) for prior years
          -  
Increase/(Decrease) for current year
     (42,740        (35,130
  
 
 
      
 
 
 
Balance at end of year
     (77,870        (35,130